Text and Data Mining valid from 2018-05-08
Received: 10 January 2018
Accepted: 12 April 2018
First Online: 8 May 2018
: Dr. Alan R. Shuldiner, in addition to his part-time appointment at the University of Maryland School of Medicine, is Vice President and Co-Head of the Regeneron Genetics Center, LLC, a fully owned subsidiary of Regeneron Pharmaceuticals, Inc. The other authors declare no competing interests.